Coronavirus Treatment Reduces Death in Severe Patients

June 22, 2020

Coronavirus Treatment Reduces Death in Severe Patients

An already available, currently low-cost steroid drug known as dexamethasone has been found to reduce the risk of death in COVID-19 patients on ventilators by a third, and for those on supplemental oxygen by a fifth. With 21 global depots and over 20 years of experience, Yourway provides high-value trial materials around the globe.

Back to Index

Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Clinical Trial Supply Europe

February 24-26, 2026
Hyatt Regency, Barcelona Tower

Schedule a Meeting

Global Clinical Supplies Group Asia Pacific Conference

March 10-12, 2026
Conrad Seoul Hotel, South Korea

Schedule a Meeting

Media

Articles

Why Integration Matters in Clinical Supply Chains

Open chat

Hello! How can I help you?